Detailed Information on Publication Record
2018
The Impact of Five VDR Polymorphisms on Multiple Sclerosis Risk and Progression: a Case-Control and Genotype-Phenotype Study
KŘENEK, Pavel, Yvonne BENEŠOVÁ, Julie BIENERTOVÁ VAŠKŮ and Anna VAŠKŮBasic information
Original name
The Impact of Five VDR Polymorphisms on Multiple Sclerosis Risk and Progression: a Case-Control and Genotype-Phenotype Study
Authors
KŘENEK, Pavel (203 Czech Republic, belonging to the institution), Yvonne BENEŠOVÁ (203 Czech Republic, guarantor, belonging to the institution), Julie BIENERTOVÁ VAŠKŮ (203 Czech Republic, belonging to the institution) and Anna VAŠKŮ (203 Czech Republic, belonging to the institution)
Edition
Journal of Molecular Neuroscience, USA, Springer New York, 2018, 0895-8696
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30103 Neurosciences
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 2.577
RIV identification code
RIV/00216224:14110/18:00102534
Organization unit
Faculty of Medicine
UT WoS
000431214500009
Keywords in English
Multiple sclerosis; Single-nucleotide polymorphism; Vitamin D receptor; EDSS; MSSS
Tags
International impact, Reviewed
Změněno: 11/2/2019 14:05, Soňa Böhmová
Abstract
V originále
Vitamin D receptor polymorphisms have been the target of many studies focusing on multiple sclerosis. However, previously reported results have been inconclusive. The objective of this study was to investigate the association between five vitamin D receptor polymorphisms (EcoRV, Fold, ApaI, TaqI. and BsmI) and multiple sclerosis susceptibility and its course. The study was carried out as a case-control and genotype-phenotype study, consisted of 296 Czech multiple sclerosis patients and 135 healthy controls. Genotyping was carried out using polymerase chain reaction and restriction analysis. In multiple sclerosis men, allele and/or genotype distributions differed in EcoRV, TaqI, BsmI, and ApaI polymorphisms as compared to controls (EcoRV, p(a) = 0.02; Taq, p(g) = 0.02, p(a) = 0.02; BsmI, p(g) = 0.02, p(a) = 0.04; ApaI, p(g) = 0.008, p(a) = 0.005). In multiple sclerosis women, differences in the frequency of alleles and genotypes were found to be significant in ApaI (controls vs multiple sclerosis women: p(g) = 0.01, p(a) = 0.05). Conclusive results were observed between multiple sclerosis women in the case of EcoRV [differences in Expanded Disability Status Scale (p = 0.05); CT genotype was found to increase the risk of primary progressive multiple sclerosis 5.5 times (CT vs CC+ TTp(corr) = 0.01, sensitivity 0.833, specificity 0.525. power test 0.823)] and Fold [borderline difference in Multiple Sclerosis Severity Score (p = 0.05)]. Our results indicate that the distribution of investigated vitamin D receptor polymorphisms is a risk factor for multiple sclerosis susceptibility and progression in the Czech population. The association between disease risk and polymorphisms was found to be stronger in men. The association of disease progression with polymorphisms was observed only in women.
Links
MUNI/A/1426/2015, interní kód MU |
| ||
MUNI/A/1549/2014, interní kód MU |
|